J-domain Protein, Jac1p, of Yeast Mitochondria Required for Iron Homeostasis and Activity of Fe-S Cluster Proteins*

Roy KimDagger §, Sandeep Saxena§, Donna M. Gordon, Debkumar Pain, and Andrew DancisDagger ||

From the Dagger  Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 and the  Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pensylvania 19104

Received for publication, November 27, 2000, and in revised form, February 14, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

J-proteins are molecular chaperones with a characteristic domain predicted to mediate interaction with Hsp70 proteins. We have previously isolated yeast mutants of the mitochondrial Hsp70, Ssq1p, in a genetic screen for mutants with altered iron homeostasis. Here we describe the isolation of mutants of the J-domain protein, Jac1p, using the same screen. Mutant jac1 alleles predicted to encode severely truncated proteins (lacking 70 or 152 amino acids) were associated with phenotypes strikingly similar to the phenotypes of ssq1 mutants. These phenotypes include activation of the high affinity cellular iron uptake system and iron accumulation in mitochondria. In contrast to iron accumulation, Fe-S proteins of mitochondria were specifically deficient. In jac1 mutants, like in ssq1 mutants, processing of the Yfh1p precursor protein from intermediate to mature forms was delayed. In the genetic backgrounds used in this study, jac1 null mutants were found to be viable, permitting analysis of genetic interactions. The Delta jac1 Delta ssq1 double mutant was more severely compromised for growth than either single mutant, suggesting a synthetic or additive effect of these mutations. Overexpression of Jac1p partially suppressed ssq1 slow growth and vice versa. Similar mitochondrial localization and similar mutant phenotypes suggest that Ssq1p and Jac1p are functional partners in iron homeostasis.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Iron is required as a cofactor for critical proteins involved in diverse biological processes including oxidation-reduction, cellular respiration, oxygen interaction, and metabolic conversions (1). However, iron can also be extremely toxic. The toxicity of iron results from interaction with reactive oxygen intermediates, generating highly toxic hydroxyl radicals that damage nearby macromolecules, including lipids, DNA, and proteins (2). Cells cope with this dual nature of iron in part by homeostatic regulation of cellular iron uptake. In Saccharomyces cerevisiae and other organisms, iron uptake is induced by iron deprivation and repressed by iron sufficiency (3). The components of the iron uptake system of yeast include a surface reductase encoded by FRE1 that is regulated by iron levels through changes in its transcription (4). We used this property of the FRE1 gene to select mutants that failed to repress FRE1 expression in response to iron. The types of mutants selected included mutants with perturbed cellular iron uptake (5, 6), iron sensing (7), or intracellular iron distribution (8, 9). This last category of mutants, which included ssq1 mutants, exhibited misregulated activation of high affinity cellular iron uptake and accumulation of iron within mitochondria (8). The SSQ1 gene encodes a low abundance Hsp70 chaperone of the mitochondrial matrix (10). We now describe the isolation of jac1 mutants with similar phenotypes using the same selection scheme. Jac1p contains a J-domain with a signature HPD (histidine, proline, aspartate) tripeptide motif (11) predicted to mediate interaction with Hsp70s (12). Thus, Jac1p may be the functional partner of Ssq1p with activity in controlling iron trafficking into the cell and mitochondria.

Culotta and co-workers (11) have identified jac1 and ssq1 mutants by using a different genetic screen that selects for improved growth of a yeast strain deficient in cytosolic superoxide dismutase (Sod1p). Mutations of jac1 or ssq1 were associated with deficient activities of Fe-S proteins (11). Fe-S clusters are modular units in which iron and sulfur are coordinated in various combinations and linked to the peptide backbone of proteins via cysteine sulfurs. Because of their ability to donate or accept electrons with tremendously varied range of potentials, these clusters are involved in many fundamental biological processes, ranging from cellular respiration to metabolic conversions (13). Although the clusters can be synthesized non-enzymatically in vitro (14), recent genetic and biochemical evidence suggests that their in vivo formation is catalyzed by specific enzymes (15-18). In bacteria, several of these proteins are associated together on the isc operon (16), and their precise biological roles in Fe-S cluster synthesis are the subject of ongoing work (19-22). Homologs of Ssq1p (called HscA or Hsc66) and Jac1p (called HscB or Hsc20) have been found on the isc operon, suggesting a role in Fe-S cluster synthesis or maintenance (16, 23). Overexpression of these proteins is required for overexpression of Fe-S proteins in bacteria (24). In a recent study, Vickery and co-workers (21) demonstrated a three-way interaction of the Hsp70 (Hsc66), a J-protein co-chaperone (Hsc20), and another isc operon-encoded protein, IscU. IscU may provide a scaffold for assembling intermediates of the Fe-S cluster assembly process (20).

Here we characterize the phenotypes of jac1 mutants with altered iron homeostasis and their similarity to phenotypes of ssq1 mutants. We also demonstrate genetic interactions between JAC1 and SSQ1.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Growth Media

Rich medium consisted of 1% yeast extract, 2% peptone, 100 µg/ml adenine, and various carbon sources. In some experiments 2% raffinose was used (YPAR), and in other experiments 2% glucose was used (YPAD). To induce the GAL10 promoter, the carbon source used was 2% raffinose and 0.5% galactose. Expression from the GAL10 promoter was turned off by growth in identical medium without galactose. For experiments with different concentrations of iron, standard defined medium with 2% raffinose was modified by omission of iron. Medium was autoclaved and iron was added back from a filter sterilized stock of 100 mM ferric ammonium sulfate. To achieve severe iron deprivation, defined medium without added iron was supplemented with 10 µM chelator bathophenanthrolene disulfonate (Fluka). Methods for growing yeast, crossing strains, sporulation, tetrad dissection, and yeast transformation have been described (25).

Yeast Strains, Mutant Selection, and Crosses

Haploid strain 61q (MATalpha , trp1-63, leu2-3,112, gcn4-101, his3-609, ura3-52, FRE1-HIS3::URA3, SSQ1::LEU2) was derived from strain 61 by insertion of an additional copy of SSQ1 carried on plasmid pRS405 and integrated at the BstEII site of the leu2-3,112 locus.

Mutant Selection-- 61q was subjected to mutagenesis by UV irradiation to produce a mortality of 40-70%. The mutagenized population was diluted and allowed to form colonies from single cells on YPAD agar plates. These colonies were replicated to agar plates containing defined medium supplemented with 10 µM copper sulfate and 20 µM ferric ammonium sulfate. After 4 days, some of the colonies developed papillae, which were streaked for single clones on YPAD plates and evaluated further. The mutants derived from 61q by this procedure included UV6.3 (jac1-3, rho°) and UV6.30 (jac1-30, rho°). The related parental strains CM3260 (MATalpha , trp1-63, leu2-3,112, gcn4-101, his3-609, ura3-52) and CM3262 (MATa, ino1-13, leu2-3,112, gcn4-101, his3-609, ura3-52) were used in crosses (5). UV6.3 and UV6.30 were backcrossed with CM3262, and spore clones were evaluated. Backcross of UV6.3 yielded spore clones 634-3C (FRE1-HIS3::URA3, jac1-3, rho+) and 8A (ura3-52, jac1-3, rho+). Backcross of UV6.30 yielded spore clones 725-3D (FRE1-HIS3::URA3, jac1-30, rho+) and 2C (ura3-52, jac1-30, rho+). In prior work, mutant selection using strain 61 yielded the mutant 191-33C (FRE1-HIS3::URA3, ssq1-4). This strain carries a mutant allele of ssq1, which is truncated at amino acid 220 of the coding region and was previously called ssc2-1 (8).

Interruption of AFT1-- In strains CM3260, 8A, and 2C, the AFT1 open reading frame (ORF)1 was interrupted by insertion of a URA3 marker gene at a unique HindIII site in the genome (7), creating strains CM3260Delta aft1, 8ADelta aft1, and 2CDelta aft1.

Meiotic Mapping-- Plasmid pRS406-JAC1 was inserted at the MscI site of the JAC1 locus in CM3262, creating strain JM1 (URA3::JAC1). JM1 was crossed with 8A (jac1-3, ura3-52) and sporulated, and the tetrads were scored for non-repressed ferric reductase (mutant iron regulatory phenotype) and Ura+ growth. All Ura+ tetrads lacked the mutant iron regulatory phenotype.

Plasmid Shuffling-- A shuffle strain for JAC1 was constructed as follows. A diploid resistant to cycloheximide, YPH501 (cyh2/cyh2), was transformed with the construct jac1KOhis. This heterozygous knockout (JAC1/Delta jac1::HIS3, cyh2/cyh2) was transformed with plasmid pRS318-JAC1, carrying the JAC1 ORF, 500 bp of 5'- and 3'-flanking region on a centromere-based plasmid with LEU2 and CYH2 genes. A tetrad clone with Leu+ and His+ growth, 729-4B, was identified and designated as a shuffle strain (MATa, ura3-52, lys2-801(amber), ade2-101(ochre), trp1-Delta 63, his3-Delta 200, leu2-Delta 1, Delta jac1::HIS3 (pRS318-JAC1)). A shuffle strain for SSQ1 was constructed in analogous fashion. The SSQ1 gene was interrupted with HIS3 in the YPH501 (cyh2/cyh2) diploid. This diploid was transformed with plasmid pRS318-SSQ1 sporulated, and a tetrad clone with Leu+ and His+ growth, MK4-6, was identified and used as a shuffle strain (MATalpha ura3-52, lys2-801(amber), ade2-101(ochre), trp1-Delta 63, his3-Delta 200, leu2-Delta 1, Delta jac1::HIS3 (pRS318-SSQ1)). For counterselection against the presence of the plasmid pRS318, cells were exposed to 10 µg/ml cycloheximide added to agar plates containing growth media (26).

Double Mutant-- The JAC1 shuffle strain 729-4B and SSQ1 shuffle strain MK4-6 were mated, and a zygote was picked by micromanipulation. The diploid was streaked on cycloheximide plates to eject the pRS318 plasmids. The diploid, which became auxotrophic for leucine, was then sporulated. Tetrads were dissected and photographed after 5 days. The spore clones were transferred to YPAD plates, and genotypes were analyzed for presence of SSQ1, Delta ssq1::HIS3, JAC1, and Delta jac1::HIS3 alleles using genomic PCR. The primers for this analysis were as follows. For JAC1, primer 011700B (5'-GACGCAAGAACAGACCTC-3') and primer 041100A (5'-CGACCACAAGGAATTTGGAAC-3') produced a product of 802 bp. For Delta jac1, primer 101499E (5'-CGCTCACCAAGCTCTTAAAACG-3') and primer 041100A (see above) produced a 539-bp product. For SSQ1, primer 021198C (5'-CCTGAAACAAACTTCAG-3') and 013098B (5'-CACCCGCTTGCCCATCAACA-3') produced a 928-bp product. For Delta ssq1, primer 101499E (see above) and 013098B (see above) produced a 275-bp product.

Plasmids and DNA Constructions

F1 was identified by screening a yeast genomic library (27) for correction of the slow growth and non-repressed reductase of 8A (jac1-3). F1 contained a 5.3-kb insert in the vector YCp50. The insert consisted of bp 458483-463769 of chromosome VII and included JAC1. The JAC1 ORF with 500 bp of flanking DNA was amplified from genomic DNA isolated from YPH501 by PCR using Pfu polymerase and inserted into the vector pCR2.1-TOPO (Invitrogen). Similarly, the ORFs and flanking regions were amplified from the 8A (jac1-3) and 2C (jac1-30) strains and inserted into the same vector. Several clones of each were subjected to DNA sequencing. The wild-type and mutant JAC1 genomic fragments with SstI and XhoI ends were subcloned into pRS406 for integration into the genome at StuI in the ura3-52 locus. The wild-type JAC1 genomic fragment was also subcloned into the same sites in pRS318 for use in plasmid shuffling. For obtaining high levels of regulated expression, the JAC1 ORF and truncated variants (with amino acids 1-114 or amino acids 1-32) were amplified from the F1 plasmid with 5' BamHI and 3' XhoI sites and cloned into pEMBlyex4-i (9). The plasmids, called GAL10-Jac1, GAL10-jac1(1-114), and GAL10-jac1(1-32) could be linearized with a unique StuI restriction site for integration at the ura3-52 site. The SSQ1 ORF was inserted into the BamHI site of the same vector and could also be linearized with the unique StuI site. The JAC1 deletion construct, jac1KOhis, was made by inserting a genomic fragment containing JAC1 and flanking region between SalI and KpnI sites into plasmid YCplac22. BamHI sites were introduced at the start and stop of the open reading frame, allowing for replacement of the entire ORF with a cassette containing the HIS3 gene. The knockout construct could be released by digestion with NotI and SstI. To delete JAC1, diploids CM3263, YPH501 (28), and W303 (29) were transformed with this fragment, and transformants were selected for growth in the absence of histidine. In each case, correct integration of the knockout was verified by PCR. For interruption/deletion of SSQ1, a HIS3 cassette with BamHI ends was inserted into BglII sites within a 2.2-kb KpnI-EcoRI SSQ1 genomic fragment carried on the vector pCRscript. For disruption of SSQ1, digestion of this plasmid with KpnI and EcoRI was performed, releasing a 3.5-kb fragment prior to transformation. The pRS318-SSQ1 plasmid carried a 3461-bp EcoRI-SalI genomic fragment containing SSQ1.

Bacterial Expression and Antibodies

For expression in bacteria, the JAC1 ORF was amplified with 5' NdeI and 3' XhoI sites and cloned into the corresponding sites of pET21b (Novagen), forming an in-frame fusion with 6 histidines (His6). Expression in BL21(DE3) was induced by 1 mM isopropyl-beta -D-1-thiogalactopyranoside for 3 h at 37 °C. The overexpressed Jac1p-His6 fusion protein was isolated from inclusion bodies, purified on a nickel-nitrilotriacetic acid column (Qiagen), and eluted with 50 mM Tris-HCl, pH 8.0, M urea, 0.4 M imidazole, and 5 mM beta -mercaptoethanol. The eluate was analyzed by SDS-polyacrylamide gel electrophoresis and found to contain a major band by staining with Coomassie Blue. The band was excised from the gel and used to inject rabbits for generation of polyclonal antibodies. The carboxyl-terminal 109 amino acids of the SSQ1 ORF was expressed in pET21b with His6 tag, purified from the soluble fraction of the bacterial lysate using the nickel-nitrilotriacetic acid column as above, and used to immunize rabbits. Antibodies directed against Aco1p (30), Mir1p, and Por1p (31) have been described previously. Commercially available antibodies used in some experiments included mouse monoclonal antibodies directed against Cox3p or Pgk1p (3-phosphoglycerate kinase) (Molecular Probes).

Fractionation of Cells

Mitochondria were isolated as described (32). The post-mitochondrial fraction was centrifuged at 386,000 × g for 20 min, and the supernatant was used as a cytosolic fraction. Intact mitochondria were resuspended in 20 mM Tris-HCl, pH 7.5, 0.6 M sorbitol. For determining the iron content of mitochondria, wild-type or mutant yeast cells were grown to steady state for 16 h in defined medium supplemented with varying concentrations of iron. A small amount (100 nM) of tracer 55Fe (Amersham Pharmacia Biotech) was added during growth. Mitochondria were isolated in the usual fashion, and an amount equivalent to 250 µg of protein was exposed to 2% SDS in 50 µl for 10 min at 55 °C and suspended in 1 ml of scintillation mixture for counting in a Beckman scintillation counter.

Mitochondrial Import

Radiolabeled precursors (Jac1p, Yfh1p, Put2p) were synthesized in a cell-free translation in the presence of a mixture of [35S]methionine and [35S]cysteine (31). Import reactions contained mitochondria (100 µg), radiolabeled preprotein, and 4 mM ATP and 1 mM GTP (31). Following import at 20 °C for 15 min, reaction mixtures were treated with trypsin (0.1 mg/ml) for 30 min at 0 °C. The protease was inactivated, and the samples were analyzed by SDS-polyacrylamide gel electrophoresis and exposed to film. Use of purified matrix processing protease (MPP) to test processing of mitochondrial precursor proteins was as described (33).

Assays for Iron Uptake, Aconitase, Succinate Dehydrogenase, and Heme Proteins

High affinity cellular iron uptake was measured as described (5). Aconitase was assayed by measuring the formation of cis-aconitate at 240 nm as described (34). Succinate dehydrogenase was assayed on mitochondria lysed in 0.5% Triton X-100 by following the reduction of p-iodonitrotetrazolium violet (INT) to INT-formazan as described (35). For detection of heme, mitochondrial proteins (100 µg) separated by polyacrylamide gel electrophoresis and transferred to nitrocellulose were incubated with peroxide developer and chemiluminescent substrates (SuperSignal ECL, Pierce) for 5 min. The covalently bound heme group of cytochrome c (Cyc1p) and the heme group of the bc1 complex (Cyt1p) were visualized by exposing the blot to film (36).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutant Alleles of jac1 Isolated in a Screen for Mutants with Altered Iron Homeostasis-- FRE1 encodes the major cell surface reductase and is required for iron acquisition from ferric iron chelates (4). The FRE1 promoter, which is repressed in response to iron, was fused to the HIS3 coding region. Mutants that failed to respond to iron-mediated repression were selected for their ability to grow in the presence of iron and in the absence of histidine (5). The most commonly selected mutants were defective in the SSQ1 gene. Therefore, in order to avoid selecting more of these mutants, the screen was modified by insertion of an additional copy of SSQ1 in the haploid genome.

Two new mutants, UV6.3 and UV6.30 (Fig. 1A), were selected and found to exhibit small colony size, non-repressing surface ferric reductase, and increased high affinity ferrous iron uptake. The mutant phenotypes were found to be recessive. The mutants were backcrossed with a wild-type parental strain, and the slow growth and iron related phenotypes segregated in a 2+:2- pattern in the tetrads, consistent with involvement of a single nuclear locus. Crosses revealed that the two independent isolates contained allelic mutations.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Panel A, strain nomenclature. The original mutant isolates obtained from the selection scheme were named UV 6.3 and UV6.30. After backcrossing to the wild-type, tetrad clones 8A and 2C were identified containing mutant alleles, called jac1-3 and jac1-30, respectively. The alleles were sequenced and the mutation in jac1-3 was found to alter nucleotide 344 of the coding from T to G, generating a stop codon at position 115. The mutation in jac1-30 was found to alter nucleotide 97 from C to T, generating a stop codon at position 33. Panel B, domain structure of Jac1p. The predicted domain structure of Jac1p includes a mitochondrial signal sequence (S), J-domain (J), and carboxyl-terminal domain of unknown function. The J-domain includes the characteristic HPD (histidine, proline, aspartate) at residues 48-50. The locations of jac1-3 and jac1-30 mutations are depicted by upward arrows. The domain structure of the bacterial J-protein Hsc20 is shown. Identity refers to the percentage of amino acid identity between Hsc20 and Jac1p in the J domain or C-terminal domain.

The wild-type allele for the mutant gene in 8A was then cloned by complementation of the slow growth and reductase phenotypes. The complementing activity was further localized to a minimal construct containing only the JAC1 ORF and 500 bp of 5'- and 3'-flanking DNA. To rule out the possibility that complementation by the JAC1-containing genomic DNA fragment could be indirect, the JAC1 ORF with its native promoter and a URA3 marker gene were inserted into the unique MscI site of the chromosomal JAC1 locus in a wild-type strain. This strain JM1 (URA3::JAC1) was crossed with 8A (jac1-3, ura3-52) and sporulated. All Ura- tetrad clones exhibited slow growth and non-repressing reductase (mutant phenotype), indicating absence of recombination between the marked wild-type JAC1 and the 8A mutant. Hence, meiotic mapping also supported that the mutation in 8A responsible for the mutant phenotypes was in JAC1 or closely linked to this locus. The mutant alleles were rescued from strains 8A (jac1-3) and 2C (jac1-30) by PCR of the JAC1 ORF and flanking regions. DNA sequence analysis revealed single nucleotide changes in each case. For the jac1-3 allele, nucleotide 344 was changed from T to G, altering codon 115 from TTA (leucine) to TGA (Stop). The jac1-3 mutant allele codes for a truncated protein lacking its carboxyl one-third. For the jac1-30 allele, nucleotide 97 was changed from C to T, altering codon 33 from CAA (glutamine) to TAA (Stop), and is thereby predicted to code for a severely truncated protein (Fig. 1).

Null Phenotype of jac1: Viability Depends on Genetic Background-- The severity of the truncation of the predicted JAC1 ORF in allele jac1-30 suggested that it would be non-functional or null. The viability of this mutant was surprising in view of an earlier work indicating that JAC1 was an essential gene required for vegetative growth (11). To directly address the question of essentiality of JAC1 in the CM3263 genetic background in which the mutants were selected, the entire ORF was deleted in this diploid, and the correctness of the deletion was verified by genomic PCR. The heterozygous knockout was sporulated and spore clones were dissected on rich (YPAD) medium and incubated at 30 °C. All four spores formed colonies, although the histidine prototrophs carrying the knockout constructs formed much smaller colonies than the wild-type spore clones (Fig. 2A). The tetrad clones containing the jac1 deletions could be maintained in culture, although they were often overgrown by more rapidly growing suppressor mutants. Similarly, in another yeast genetic background, YPH501, jac1 knockouts germinated and formed small colonies (Fig. 2A). This slow growth phenotype of the jac1 deletion was more severe when incubated at elevated (37 °C) or lower (23 °C) temperatures (data not shown). Thus, in both of these yeast strains, jac1 deletion was deleterious but still allowed germination and vegetative growth. We also examined the deletion phenotype in W303, another commonly used parental strain. In this background, the jac1 deletion underwent germination and formed tiny macroscopic colonies consisting of several thousand cells (Fig. 2A, enlarged panel). However, these clones could not be propagated. Perhaps small amounts of Jac1p carried over from the diploid into the deletion spore clones supported a finite number of doublings prior to growth arrest. In summary, JAC1 is required for vegetative growth in some yeast genetic backgrounds and not in others.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 2.   Panel A, null phenotype of jac1 depends on genetic background. Heterozygous deletions of JAC1 were constructed in diploid strains: YPH501, CM3263, and W303. These strains were sporulated; tetrads were dissected, arrayed in vertical columns on rich medium agar plates, and incubated at 30 °C for 4 days. In the YPH501 panel, column 5 was not a true tetrad. In the W303 panel, column 4 (tetrad 4) was photographed at higher magnification and this is shown in the right-hand panel. Panel B, JAC1 alleles examined by plasmid shuffling. JAC1 shuffle strain, 729-4B (Delta jac1::HIS3, (pRS318-JAC1)), was transformed with various constructs targeted to the ura3-52 locus. These constructs were: 1, pRS406, empty vector; 2, pRS406-JAC1, wild-type JAC1 allele including the native promoter; 3, GAL10-Jac1, JAC1 ORF under the control of the GAL10 promoter; 4, GAL10-jac1-(1-114), truncated Jac1p of 114 amino acids under the control of the GAL10 promoter; 5, GAL10-jac1-(1-96), truncated Jac1p of 96 amino acids under the control of the GAL10 promoter. The transformants were analyzed by plating 5-fold dilutions of 1 × 105, cells in a 5-µl volume on agar plates containing YPAR supplemented with 0.5% galactose to induce the GAL10 promoter and 10 µg/ml cycloheximide to counterselect against the covering plasmid. Plates were incubated at 30 °C for 4 days before photography. For measurement of high affinity ferrous iron uptake, cells were taken from the photographed plates and grown under inducing conditions (YPAR with 0.5% galactose) prior to assay of high affinity ferrous iron uptake using 55Fe radionuclide.

Mutant jac1 Phenotype Reconstituted by Plasmid Shuffling-- In genetic backgrounds in which the jac1 null strain was viable, it was extremely slow growing and accumulated suppressor mutations. To accurately assess the phenotype of mutants and to more easily work with strains carrying mutated forms of JAC1, we used a plasmid shuffle strategy as is used to study essential genes (26). The phenotype of the deletion (Fig. 2B, line 1) uncovered after plasmid shuffle was characterized by slow growth and increased cellular iron uptake (Fig. 2B, compare lines 1 and 2). Jac1p expressed from a galactose-induced (GAL10) promoter completely corrected the slow growth and iron uptake phenotypes of the mutant (Fig. 2B, line 3). Jac1p truncations were constructed corresponding to the jac1-3 (amino acids 1-114) and jac1-30 (amino acids 1-32) mutations, and these were placed under the control of a GAL10 promoter in the shuffle strain. When these mutated forms of Jac1p were expressed by turning on the promoter, the growth properties and iron uptake levels remained indistinguishable from deletion mutants (Fig. 2B, compare lines 1, 4, and 5). Under these inducing conditions, expression of truncated Jac1p (amino acids 1-114) from the GAL10 promoter was 3-4-fold increased compared with the wild-type protein expressed from the native promoter (data not shown). The results suggest that the C-terminal domain of Jac1p (amino acids 115-184) is required for protein function.

Misregulated Cellular Iron Uptake of jac1-3 and jac1-30 Mutants: Dependence on AFT1-- Mutant strains 8A (jac1-3) and 2C (jac1-30) exhibited activity of the FRE1-HIS3 fusion gene under iron replete repressing conditions (Fig. 3A). Surface reductase activity likewise was not repressed by iron addition to the medium (not shown). The parental strain and the two mutants, 8A (jac1-3) and 2C (jac1-30), were grown in media with different concentrations of iron. The cells were washed and high affinity ferrous iron uptake was measured by incubation with 1 µM 55Fe radionuclide (Fig. 3B). Under iron starvation conditions, iron transport activities of wild-type and mutants were similar; however, exposure to iron in the growth media progressively repressed cellular iron uptake in wild-type cells to a much greater extent than in the mutants (Fig. 3B).


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 3.   Panel A, misregulation of FRE1 in jac1-3 and jac1-30 mutants. Strains carrying the FRE1-HIS3 construct integrated into the genome of a Delta his3 strain were evaluated for their ability to grow on standard defined medium (1 µM iron) in the absence or presence of histidine. Strains 61q (JAC1), 634-3C (jac1-3), and 725-3D (jac1-30), all of which contained the FRE1-HIS3 construct integrated into the genome, were evaluated for their ability to grow on standard defined medium in the absence or presence of histidine. Growth of jac1-3 and jac1-30 mutants on the histidine-free plate reflects activity of the FRE1-HIS3 fusion under iron replete conditions. Panel B, misregulated cellular iron uptake in jac1 mutants. Yeast strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) were grown in modified defined medium. This medium contained glucose as a carbon source and iron chelator bathophenanthrolene disulfonate (10 µM) or different concentrations of iron (0, 0.1, 0.2, 0.5, 1, 2, 5, 10, and 20 µM) added as ferric ammonium sulfate. The cells were grown to stationary phase, diluted 10-fold into media of the same composition, and allowed to enter logarithmic growth prior to assay of high affinity ferrous iron uptake using 55Fe radionuclide. Panel C, increased high affinity ferrous iron uptake in the jac1 mutants is AFT1-dependent. Strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) were each transformed with a construct to interrupt the AFT1 gene. Strains were grown in YPAD, and iron uptake was measured.

Aft1p is a DNA-binding protein that interacts with target consensus sequences in the promoters of iron-regulated genes. In the absence of iron, Aft1p binds to these sequences and activates transcription. Aft1p thereby controls iron-dependent expression of the components of the high affinity ferrous transport system (37). We wondered if the aberrant induction of high affinity ferrous transport observed for the jac1 mutants was mediated via Aft1p. To address this question, the AFT1 gene was interrupted and high affinity ferrous uptake was measured in the jac1Delta aft1 double mutants. The results showed equivalent low levels of uptake for all strains lacking AFT1, regardless of the absence or presence of jac1 mutations (Fig. 3C). Therefore, the increased cellular iron uptake due to jac1 mutations was completely dependent on an intact copy of AFT1.

Mitochondrial Iron Accumulation in jac1 Mutants Subjected to Iron Stress-- Wild-type and jac1 mutant strains were grown in media containing different concentrations of iron with 55Fe added as a tracer. After 16 h of growth, mitochondria were isolated and radiolabeled iron was determined by scintillation counting. At the lowest medium iron concentration of 0.1 µM, mitochondrial iron in the wild-type was 0.36 pmol/µg of protein versus 1.0 and 1.0 for the jac1-3 and jac1-30 mutants. These mitochondrial iron values for the mutants are equivalent or below levels of mitochondrial iron in wild-type strains grown in standard defined medium (usually 1-3 pmol/µg). With increasing amounts of iron in the growth media, jac1-3 and jac1-30 mutants accumulated tremendously increased amounts of iron in mitochondria (Fig. 4). For the jac1-3 mutant grown in 1, 5, or 50 µM iron, mitochondrial iron was increased to 26, 127, or 395 pmol/µg protein. For the jac1-30 mutant the levels were 32, 186, and 348 pmol/µg protein, respectively. These results indicate that the jac1-3 and jac1-30 mutations lead to abnormal trafficking of iron to mitochondria.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Accumulation of mitochondrial iron in jac1 mutants. Yeast strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) were grown in defined medium containing 2% raffinose and varying concentrations of iron (0.1, 1.0, 5.0, and 50 µM). 55Fe radionuclide was added as a tracer, and, after 16 h of growth, mitochondria were isolated and the iron content determined by scintillation counting of radionuclide in the samples. The iron content is displayed as picomoles of iron per microgram of mitochondrial protein.

Deficient Iron-Sulfur and Heme Proteins in jac1 Mutants-- Iron-sulfur proteins were evaluated in the jac1-3 and jac1-30 mutants. Aconitase (Aco1p) is a mitochondrial protein (38), which contains a 4Fe-4S cluster required to catalyze the conversion of citrate to isocitrate (34). Aconitase protein level and activity in the wild-type strain were not affected by iron content of the growth medium (Fig. 5A). By contrast, in the mutants, aconitase protein was so severely decreased that it was not detected by immunoblotting. The activity assay was more sensitive, and some residual activity was noted in the jac1 mutants. Interestingly, this residual activity was dependent on the iron content of the mitochondria. In mitochondria isolated from the mutants grown in low iron media, aconitase activity was present at ~10% of wild-type levels, whereas in the mitochondria isolated from iron stressed cells exposed to 50 µM iron in the medium, activity was further decreased or undetectable. In summary, aconitase protein and activity were markedly diminished in the jac1 mutants under all growth conditions. Iron accumulation within mitochondria could be correlated with abrogation of the small amount of residual aconitase activity, suggesting a toxic effect. Succinate dehydrogenase (SDH), a protein complex of the inner membrane containing Fe-S and heme cofactors, was also evaluated (39). Like aconitase, SDH activity was markedly decreased in the mutants under all conditions, and the small amount of residual activity (6% or less) appeared to be further compromised by growth in high iron media (Fig. 5B).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Panel A, deficiency of aconitase protein and activity in jac1 mutants. Aconitase activity was assayed in mitochondria isolated from yeast strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) grown in defined medium with different iron concentrations (0.1, 1.0, 5.0, and 50 µM). The units of activity are nanomoles of cis-aconitate/mg of mitochondrial protein/min. The aconitase protein level (Aco1p, 85 kDa) was assayed by immunoblotting with a monospecific antibody. delta -1-Pyrroline-5-carboxylate dehydrogenase (Put2p, 61 kDa), a mitochondrial matrix protein, was evaluated as a control. Panel B, deficiency of SDH activity in jac1 mutants. SDH was assayed in the various mitochondria described in panel A. The units of activity are nanomoles of INT-formazan/mg of mitochondrial protein/min. Mean and standard deviations of three replicate assays for aconitase and SDH activity are depicted.

Iron is inserted into heme in mitochondria (40), and many heme proteins are found in mitochondria. Therefore, the status of several heme proteins was evaluated in the jac1 mutants. Cytochrome c (Cyc1p) and cytochrome bc1 (Cyt1p) are nuclear-encoded mitochondrial proteins that contain covalently bound heme. The heme in these proteins can be visualized using enhanced chemiluminescence substrates by virtue of its intrinsic peroxidase activity (36). Cyt1p and Cyc1p heme levels in mitochondria were markedly decreased in the jac1-3 and jac1-30 mutants (Fig. 6), even at the lowest medium iron concentration tested. The levels were further reduced in mitochondria with increased iron content. Likewise, mitochondrially encoded cytochrome oxidase subunit 3 protein (Cox3p) was also reduced in the jac1-3 and jac1-30 mutants (Fig. 6). This decrease could reflect lack of heme or destruction of heme in the cytochrome oxidase complex, because the proteins of the complex are destabilized in the absence of heme cofactor (data not shown). Alternatively, this decrease of Cox3p in jac1 mutants could result from mitochondrial DNA damage.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 6.   Deficiency of heme proteins in jac1 mutants. Mitochondria were isolated from yeast strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) grown in defined medium and exposed to varying concentrations of iron (0.1, 1.0, 5.0, and 50 µM). Porin (Por1p, 31 kDa), a mitochondrial outer membrane protein, was evaluated as a control. Heme groups in cytochrome c (Cyc1p heme, 12 kDa) and the bc1 heme complex of cytochrome c1 (Cyt1p heme, 31 kDa) were evaluated by heme blotting. Cytochrome oxidase subunit 3 (Cox3p, 24 kDa) was assayed by immunoblotting with a monoclonal antibody.

Cellular Depletion of Jac1p-- Jac1p was placed under the control of the inducible GAL10 promoter, and the wild-type allele was replaced with this regulated construct using the shuffle strategy. As expected, under inducing conditions for the GAL10 promoter, Jac1p was highly expressed (Fig. 7A). This strain grew well and was phenotypically indistinguishable from the wild-type. When the inducer was removed, Jac1p was no longer expressed and was depleted from the cells (Fig. 7A), and yet surprisingly, even after prolonged incubations or addition of glucose, which is known to repress this promoter, no slowing of growth was noted (data not shown). When we further evaluated this strain grown in the absence of inducer, phenotypes noted for the jac1 mutants were found to be present to variable degrees. High affinity iron uptake was increased 3-fold compared with wild-type (Fig. 7A). Aconitase and SDH activities were decreased to 56% and 49% of wild-type levels, respectively (Fig. 7B). In contrast with the jac1 mutants in which aconitase protein and activity were coordinately decreased, in these Jac1p depletion experiments, aconitase activity was decreased but Aco1p protein level was unaltered. The implication is that inactive Aco1p was being generated. The inactive protein might contain a 3Fe-4S cluster as has been described for oxidatively damaged aconitase (13). Alternatively, it may contain no cluster at all (apoprotein) due to loss of the cluster or failure to insert the cluster into newly synthesized protein. Furthermore, in the Jac1p depletion experiments, heme in Cyt1p and Cyc1p was not affected, as distinguished from the jac1 mutant phenotype (Fig. 7C). Thus, the phenotypes resulting from Jac1p depletion were more mild than the phenotypes of the jac1 mutants, perhaps because some minimal level of Jac1p was expressed from the GAL10 promoter even under non-inducing conditions.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   Depletion of Jac1p. The JAC1 ORF was placed under the control of the GAL10 promoter and the wild-type allele in YPH499 was replaced with this regulated construct, GAL10-Jac1. The wild-type strain, YPH499, and the GAL10-Jac1 strain were grown in non-inducing medium (2% raffinose, no galactose) for 96 h. During this period, cells were maintained in logarithmic growth by dilution once each day. Panel A, Jac1p was evaluated by immunoblotting on purified mitochondria, and iron uptake was measured on whole cells. Panel B, aconitase protein (Aco1p) was assayed by immunoblotting; aconitase activity and SDH activity were assayed on purified mitochondria. Panel C, heme cofactor in cytochrome c (Cyc1p heme) and cytochrome c1 of the bc1 complex (Cyt1p heme) were evaluated by heme blotting.

Mutant (jac1-3) Is Not Generally Defective in Precursor Protein Translocation but Is Defective in Yfh1p Processing-- The J-proteins of mitochondria, Mdj1p and Mdj2p, cooperate with the Hsp70, Ssc1p, in mediating import and folding of precursor proteins (41, 42). To determine if jac1 mutants were generally defective in protein import, we compared translocation of Put2p precursor into mitochondria isolated from wild-type and jac1-3 strains. Put2p is a mitochondrial matrix protein involved in proline biosynthesis. The Put2p precursor was synthesized in reticulocyte lysate in the presence of [35S]methionine (Fig. 8A, lane 1). When incubated with mitochondria, a more rapidly migrating mature form was generated due to removal of the mitochondrial signal sequence (lane 2), and this mature form was protected from externally added protease (lane 3). The import, processing, and generation of the mature protected Put2p were unaffected in ssq1-4 mutant mitochondria (lanes 4 and 5) or in jac1-3 mutant mitochondria (lanes 6 and 7). In summary, a general import defect was not observed, and consistent with the import results, the steady state levels of Put2p were not diminished in jac1-3 mitochondria (see Fig. 5A).


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 8.   Panel A, import of Put2p into isolated mitochondria. The Put2p precursor (delta -1-pyrroline-5-carboxylate dehydrogenase) was synthesized in reticulocyte lysate in the presence of [35S]methionine. The precursor (lane 1) was incubated with 100 µg of isolated mitochondria (Mito) from strains 61 (WT, lanes 2 and 3), 191-33C (ssq1-4, lanes 4 and 5), or 8A (jac1-3, lanes 6 and 7). After 15 min, samples were exposed to 0.1 mg/ml trypsin (Trypsin, lanes 3, 5, and 7), and the protease was inactivated. The mitochondria were retrieved by pelleting at 12,000 × g and analyzed by SDS-polyacrylamide electrophoresis. The Put2p precursor (p) and mature forms (m) are indicated. Panel B, the Yfh1p precursor radiolabeled by synthesis in reticulocyte lysate (lane 1) consisted of the full-length product (p) and a truncated form arising from internal initiation (*). The mitochondrial import assay was performed as described in panel A. Yfh1p precursor was processed in two steps, and in ssq1-4 and jac1-3 mutant mitochondria, both the intermediate form (i) and mature (m) forms were observed.

An unusual defect in the processing of Yfh1p precursor was observed in ssq1 mutant mitochondria (8, 43). Yfh1p, the yeast frataxin homolog, is required for iron homeostasis (44). The precursor is nuclear encoded, imported into mitochondria, and proteolytically processed at the amino terminus in two steps by the matrix processing peptidase (45, 46). In ssq1 mutants, the second processing cleavage is impaired. Although the functional significance of this observation is not yet clear, we reasoned that if Ssq1p functions with Jac1p, the jac1 mutant might exhibit a similar defect in Yfh1p processing. Therefore, Yfh1p precursor was radiolabeled (Fig. 8B, lane 1) and imported into wild-type and mutant mitochondria. In the wild-type mitochondria, the precursor was rapidly processed to the mature form (m) and protected from external protease (Fig. 8B, lanes 2 and 3). The intermediate form (i) generated by the first processing cleavage was not observed. In ssq1 mitochondria, most of the precursor remained in this intermediate, partially processed form (i), and this was protected from external protease (Fig. 8B, lanes 4 and 5). In the jac1-3 mitochondria, the intermediate was again observed, reflecting delay in the second processing step of Yfh1p, although the severity of the defect was not as great as in the ssq1 mutant (Fig. 8B, lanes 6 and 7). In summary, both ssq1 and jac1 mutant mitochondria do not manifest general import defects but exhibit similar defects in Yfh1p maturation.

Jac1p Localized to Mitochondria in the Wild-type and Undetected in the Mutants-- The initial description of Jac1p noted a potential mitochondrial leader sequence at the amino terminus of the predicted ORF (11). To experimentally address the question of whether the JAC1 ORF includes a mitochondrial signal sequence, the Jac1p precursor protein was synthesized and radiolabeled in reticulocyte lysate (Fig. 9A, lane 1). When the Jac1p precursor was incubated with purified MPP, the protein was processed to a more rapidly migrating form (lane 2). Incubation with mitochondria also generated a species with identical mobility (lane 3). The generation of the mature product was dependent on the presence of a membrane potential and was completely inhibited by the addition of valinomycin (lanes 4 and 6). The mature processed species formed after import was protected from externally added protease indicating that this is the translocated, processed form (lane 5). Thus, Jac1p preprotein is imported into mitochondria and proteolytically processed to a mature form by MPP. Comparison of the precursor and mature forms would be consistent with the removal of a 13-amino acid mitochondrial signal sequence at the amino terminus of Jac1p.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 9.   Panel A, import and processing of Jac1p precursor into isolated mitochondria. The radiolabeled Jac1p precursor was treated with MPP (lane 2) or incubated with 100 µg of wild-type mitochondria (lanes 3-6). In some cases, 5 µg/ml valinomycin (Val, lanes 4 and 6) was added to the mitochondria prior to the addition of the precursor. After 15 min, samples were exposed to 0.1 mg/ml trypsin (Trypsin, lanes 5 and 6), and the protease was inactivated. The mitochondria were retrieved by pelleting at 12,000 × g and analyzed by SDS-polyacrylamide electrophoresis. The Jac1p precursor (p) and mature forms (m) are indicated. Panel B, Jac1p unregulated by iron in the wild-type and undetectable in the jac1 mutants. Mitochondria were isolated from strains CM3260 (JAC1), 8A (jac1-3), and 2C (jac1-30) grown in 0.1, 1, 5, or 50 µM iron added to modified defined medium. The mitochondria were probed with antibodies to Jac1p or Put2p (delta -1-pyrroline-5-carboxylate dehydrogenase). Jac1p migrated at 23 kDa, and Put2p migrated at 61 kDa. Panel C, localization of Jac1p in cells. A cytoplasmic fraction (C) was compared with a mitochondrial fraction (M) isolated from wild-type cells (YPH499). These fractions were evaluated by immunoblotting with antibodies against Jac1p (23 kDa), Mir1p (32 kDa), a protein of the mitochondrial inner membrane, and Pgk1p (45 kDa), 3-phosphoglycerate kinase, a cytoplasmic protein.

The localization of Jac1p in cells was examined. Immunoblotting of purified mitochondria from the wild-type strain CM3260 revealed a specific signal migrating at 23 kDa representing mature Jac1p (Fig. 9B). The abundance of Jac1p was unchanged in mitochondria isolated from wild-type yeast grown in widely different concentrations of iron, from 0.1 to 50 µM, indicating lack of iron dependent regulation of protein levels (Fig. 9B). In the mutants, jac1-3 and jac1-30, Jac1p was not detected (Fig. 9B), even with overexposure of the immunoblot (data not shown). Thus, the jac1-3 and jac1-30 mutants appeared to be null mutants. A cytoplasmic fraction was examined by immunoblotting. Jac1p and Mir1p, a mitochondrial marker protein, were not detected in this fraction, whereas 3-phosphoglycerate kinase (Pgk1p), a cytoplasmic marker protein, was present (Fig. 9C). The data indicate that, within the detection limits of our antibody, Jac1p was found in mitochondria but not in cytoplasm.

Genetic Interaction of JAC1 and SSQ1-- The viability of ssq1 and jac1 individual deletions provided an opportunity to perform epistatic analysis of these two genes. Shuffle strains carrying ssq1 and jac1 deletions were mated. After counterselection against the covering plasmids, the double heterozygote was sporulated and tetrads were analyzed. Many tetrads contained four viable spore clones, and parental ditypes, non-parental ditypes, and tetratypes were identified (Fig. 10A, columns 1, 2, and 3-5, respectively). The Delta ssq1 spore clones formed small colonies (Delta s), Delta jac1 spores formed smaller colonies (Delta j), and the double mutants formed tiny, albeit viable colonies (Delta Delta ). In many cases, the double mutant spore clones did not grow after inoculation of liquid or solid media cultures. Thus, the double mutants were clearly more compromised than either of the single mutants in terms of viability and growth. The data suggest that the two genes may serve some overlapping and some non-overlapping functions.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 10.   Genetic interactions of SSQ1 and JAC1. Panel A, synthetic effects of combining Delta jac1 and Delta ssq1 mutations. Shuffle strains for JAC1 and SSQ1 were mated, and the diploid was treated with cycloheximide to counterselect against the covering plasmids for both genes. The diploid was sporulated, and PCR was used to analyze the tetrads for segregation of JAC1, Delta jac1::HIS3, SSQ1, and Delta ssq1::HIS3 alleles. Typical tetrads are shown: 1 (parental ditype), 2 (non-parental ditype), and 3-5 (tetratypes) The corresponding mutant genotypes are shown in the table below: Delta j (Delta jac1::HIS3), Delta s (Delta ssq1::HIS3), Delta Delta (Delta jac1::HIS3, Delta ssq1::HIS3). Panel B, overexpression effects. The SSQ1 shuffle strain (MK4-6) was transformed with integrating plasmids linearized at StuI and targeted to the ura3-52 locus: pRS406 (1), pRS406-SSQ1 (2), GAL10-Ssq1 (3), or GAL10-Jac1 (4). The JAC1 shuffle strain (729-4B) was similarly transformed with the integrating plasmids: pRS406 (5), pRS406-JAC1 (6), GAL10-Ssq1 (7), and GAL10-Jac1 (8). The transformants were suspended in water, and 5-fold dilutions of 105 cells were plated on agar plates containing 2% raffinose, 0.5% galactose, and 10 µg/ml cycloheximide to counterselect against the covering plasmids. Panel C, strains YPH499 (1) or YPH499 transformed with GAL10-Ssq1 (2) or GAL10-Jac1 (3) were grown in medium containing 2% raffinose and 0.5% galactose. Strains 61 (4), 191-33C (ssq1-4) (5), and 8A (jac1-3) (6) were grown in medium containing 2% raffinose. Mitochondria were isolated and analyzed by immunoblotting with antibodies to Ssq1p, Jac1p, and Put2p.

Additional support for this assertion is provided by overexpression experiments. Overexpression of Jac1p in Delta ssq1 mutants clearly suppressed the slow growth phenotype (Fig. 10B, compare 1 versus 4). Overexpression of Ssq1p in Delta jac1 mutants also enhanced growth, but the effect was not as marked (Fig. 10B, compare 7 to 5). Approximately 3-fold overexpression of Jac1p was achieved without overexpression of Ssq1p, and vice versa overexpression of Ssq1p was achieved without overexpression of Jac1p (Fig. 10C). In the mutant 33C (ssq1-4), Ssq1p was undetectable without alteration of the Jac1p level, and in strain 8A (jac1-3), Jac1p was undetectable without alteration of the Ssq1p level (Fig. 10C).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutant jac1 allele mutants were isolated by their ability to activate the FRE1-HIS3 gene fusion, an indicator of abnormal iron homeostasis. Mutant jac1 cells failed to repress cellular iron uptake appropriately in response to iron exposure, and the excess iron accumulated within mitochondria. The iron regulatory phenotype was tightly coupled with Fe-S protein deficiency. The most straightforward explanation for the findings is that Jac1p is involved in the biogenesis of one or more iron-sulfur protein regulators (47). Loss of Jac1p function, then, might result in failure to properly form these regulatory Fe-S cluster proteins, which in turn leads to failure to turn off iron uptake to the cell and iron accumulation in mitochondria. The identity of putative Fe-S cluster protein regulators of iron trafficking remains to be determined. Aft1p, an iron-sensor regulator that works by controlling transcription of target genes (7), is required for the induced cellular iron uptake of jac1 mutants. Aft1p might itself contain an Fe-S cluster or interact with another protein that contains a cluster. However, mitochondrial iron accumulation does not occur with activated AFT1 alleles, and so accumulation of mitochondrial iron may be due to effects of mutated jac1 on an unidentified regulatory protein. IRP1 in mammals is an Fe-S protein with regulatory effects on iron trafficking (48), although an orthologous protein in yeast has not been described.

Jac1p belongs to the class of J-domain chaperones predicted to interact with Hsp70 proteins. We have now provided evidence to suggest that Ssq1p is the Hsp70 partner for Jac1p. The mutant phenotypes resulting from loss-of-function mutations in either jac1 or ssq1 were extremely similar. Mutant alleles of both genes were selected in screens for abnormal iron homeostasis or Delta sod1 suppression (11). The iron trafficking abnormalities were similar for both mutants, characterized by induction of high affinity cellular iron uptake and accumulation in mitochondria. Mutants of jac1 and ssq1 (11, 49) exhibited multiple Fe-S protein deficiencies. Protein translocation into jac1 or ssq1 (10) mutant mitochondria was not generally impaired. However, a delay in the second processing cleavage of translocated Yfh1p was observed for both mutant mitochondria in in vitro import assays. Finally, genetic evidence for the interaction exists. The double mutant (Delta ssq1 Delta jac1) was even more slow growing than either single mutant, indicating an additive or synthetic effect. The overexpression of Jac1p was able to significantly compensate for the slow growth of the Delta ssq1 mutant, and reciprocally the overexpression of Ssq1p was able to slightly compensate for the slow growth of the Delta jac1 mutant. Finally, both Ssq1p (10) and Jac1p have been localized to mitochondria and thus reside in the same cellular compartment, as would be required for them to interact.

Hsp70s are structurally similar proteins that contain an ATP-binding domain and a peptide-binding domain evolved to interact with unfolded proteins (50). Family members exist in various cellular compartments and function by binding unfolded proteins, thereby preventing aggregation or assisting translocation (50). A chief function of J-proteins is to enhance delivery of chaperone substrates to the partner Hsp70. The J-protein may also enhance the ATPase activity of the Hsp70 (51). Subsequently, after ATP hydrolysis, the peptide substrate binds more tightly to the chaperone, allowing it time to fold (50). However, J-proteins and Hsp70s may interact with different unfolded protein substrates and may even exhibit independent chaperone activities (50). The data on the synthetic effects of the mutants and the cross suppression data are consistent with the existence of both independent and cooperating functions for Hsp70 and J-proteins.

A key question relates to the identity of the substrates for this specialized chaperone system. In view of the specific impairment in various Fe-S cluster proteins in the jac1 and ssq1 mutants, Fe-S cluster proteins might constitute chaperone substrates. Most mitochondrial proteins, including Fe-S proteins, are synthesized on cytoplasmic ribosomes and translocated into mitochondria as unfolded intermediates (52). At this stage these apoproteins probably lack Fe-S cofactors and may be prone to aggregation. Specifically dedicated chaperones could protect the apoprotein while an Fe-S cluster is inserted and then assist folding or assembly of the active conformation. Alternatively, specialized proteins that mediate Fe-S cluster synthesis might be the chaperone substrates. Elegant work suggests that several proteins associated on the isc operon of E. coli mediate in vivo synthesis or maintenance of Fe-S clusters (16, 20), and these might require special chaperones for their assembly or activation. Recent data from Vickery and co-workers (21) show that the IscU protein, proposed to be a scaffold on which Fe-S cluster assembly occurs, interacts with high affinity with the HscA (homologous to Ssq1p) and HscB (homologous to Jac1p) chaperones. This strongly suggests that, in bacteria, IscU is a physiologic substrate, although perhaps not the only one. In yeast, the IscU homologs, Isu1p and Isu2p, are mitochondrial proteins that are important for iron homeostasis (49). Another protein that could be a substrate for the Ssq1p and Jac1p chaperones is Yfh1p. Yfh1p, the yeast frataxin homolog, is clearly involved in cellular and mitochondrial iron homeostasis (44), although the prokaryotic homolog is not located on the isc operon (16).

Many questions remain, and an interesting unresolved question relates to the evolutionary conservation of these chaperones. IscS and IscU, proteins involved in Fe-S cluster formation (20), are conserved from bacteria (isc operon) to yeast to humans (53, 54). Ssq1p and Jac1p are related to orthologous genes on bacterial isc operons implicated in Fe-S cluster synthesis or maintenance (16, 23). Therefore, it is possible that Jac1p and Ssq1p chaperones will also be found in higher eukaryotes. If human homologs of Jac1p and Ssq1p exist, they might be important in human diseases of iron trafficking, such as some neurodegenerative diseases (55) and sideroblastic anemias (56-58).

    FOOTNOTES

* This work was supported by Hematology Clinical Research Grant T32 HL 07439-21 (to R. K.), National Institutes of Health Grant DK53953 (to A. D.), National Institutes of Health Grant GM57067 and American Heart Association Grant 9951300U (both to D. P.), and National Research Service Award Fellowship NS11166 (to D. M. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These authors contributed equally to this work.

|| To whom correspondence should be addressed. Tel.: 215-573-6275; Fax: 215-573-7049; E-mail: adancis@mail.med.upenn.edu.

Published, JBC Papers in Press, February 27, 2001, DOI 10.1074/jbc.M010695200

    ABBREVIATIONS

The abbreviations used are: ORF, open reading frame; PCR, polymerase chain reaction; SDH, succinate dehydrogenase; MPP, matrix processing peptidase; bp, base pair(s); kb, kilobase pair(s); INT, p-iodonitrotetrazolium violet.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Brittenham, G. (2000) in Hematology: Basic Principles and Practice (Hoffman, R. , Benz, E. , Shattil, S. , Furie, B. , Cohen, H. , Silberstein, L. , and McGlave, P., eds) , pp. 397-428, Churchill Livingstone, Philadelphia
2. Halliwell, B., and Gutteridge, J. M. C. (1991) Free Radicals in Biology and Medicine , Clarendon, Oxford, United Kingdom
3. Askwith, C. C., de Silva, D., and Kaplan, J. (1996) Mol. Microbiol. 20, 27-34[Medline] [Order article via Infotrieve]
4. Dancis, A., Roman, D. G., Anderson, G. J., Hinnebusch, A. G., and Klausner, R. D. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3869-3873[Abstract]
5. Dancis, A., Yuan, D. S., Haile, D., Askwith, C., Eide, D., Moehle, C., Kaplan, J., and Klausner, R. D. (1994) Cell 76, 393-402[Medline] [Order article via Infotrieve]
6. Stearman, R., Yuan, D. S., Yamaguchi-Iwai, Y., Klausner, R. D., and Dancis, A. (1996) Science 271, 1552-1557[Abstract]
7. Yamaguchi-Iwai, Y., Dancis, A., and Klausner, R. D. (1995) EMBO J. 14, 1231-1239[Abstract]
8. Knight, S. A., Sepuri, N. B., Pain, D., and Dancis, A. (1998) J. Biol. Chem. 273, 18389-18393[Abstract/Free Full Text]
9. Li, J., Kogan, M., Knight, S., Pain, D., and Dancis, A. (1999) J. Biol. Chem. 274, 33025-33034[Abstract/Free Full Text]
10. Schilke, B., Forster, J., Davis, J., James, P., Walter, W., Laloraya, S., Johnson, J., Miao, B., and Craig, E. (1996) J. Cell Biol. 134, 603-613[Abstract]
11. Strain, J., Lorenz, C. R., Bode, J., Garland, S., Smolen, G. A., Ta, D. T., Vickery, L. E., and Culotta, V. C. (1998) J. Biol. Chem. 273, 31138-31144[Abstract/Free Full Text]
12. Johnson, J. L., and Craig, E. A. (1997) Cell 90, 201-204[Medline] [Order article via Infotrieve]
13. Beinert, H. (2000) J. Biol. Inorg. Chem. 5, 2-15[CrossRef][Medline] [Order article via Infotrieve]
14. Holm, R. H. (1992) Adv. Inorg. Chem. 38, 1-71
15. Zheng, L., White, R., Cash, V., Jack, R., and Dean, D. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2754-2758[Abstract]
16. Zheng, L., Cash, V., Flint, D., and Dean, D. (1998) J. Biol. Chem. 273, 13264-13272[Abstract/Free Full Text]
17. Schwartz, C. J., Djaman, O., Imlay, J. A., and Kiley, P. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 9009-9014[Abstract/Free Full Text]
18. Skovran, E., and Downs, D. M. (2000) J. Bacteriol. 182, 3896-3903[Abstract/Free Full Text]
19. Zheng, L., and Dean, D. (1994) J. Biol. Chem. 269, 18723-18726[Abstract/Free Full Text]
20. Yuvaniyama, P., Agar, J., Cash, V., Johnson, M., and Dean, D. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 599-604[Abstract/Free Full Text]
21. Hoff, K. G., Silberg, J. J., and Vickery, L. E. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 7790-7795[Abstract/Free Full Text]
22. Kambampati, R., and Lauhon, C. T. (2000) J. Biol. Chem. 275, 10727-10730[Abstract/Free Full Text]
23. Vickery, L. E., Silberg, J. J., and Ta, D. T. (1997) Protein Sci. 6, 1047-1056[Abstract/Free Full Text]
24. Nakamura, M., Saeki, K., and Takahashi, Y. (1999) J. Biochem. (Tokyo) 126, 10-18[Abstract]
25. Sherman, F., Fink, G. R., and Hicks, J. B. (1986) Laboratory Course Manual for Methods in Yeast Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
26. Sikorski, R. S., and Boeke, J. D. (1991) Methods Enzymol. 194, 302-318[Medline] [Order article via Infotrieve]
27. Rose, M. D., Novick, P., Thomas, J. H., Botstein, D., and Fink, G. R. (1987) Gene (Amst.) 60, 237-243[CrossRef][Medline] [Order article via Infotrieve]
28. Brachmann, C. B., Davies, A., Cost, G. J., Caputo, E., Li, J., Hieter, P., and Boeke, J. D. (1998) Yeast 14, 115-132[CrossRef][Medline] [Order article via Infotrieve]
29. Meyers, A. M., Pape, L. K., and Tzagoloff, A. (1985) EMBO J. 4, 2087-2092[Abstract]
30. Li, J., Saxena, S., Pain, D., and Dancis, A. (2001) J. Biol. Chem. 276, 1503-1509[Abstract/Free Full Text]
31. Schulke, N., Sepuri, N. B., Gordon, D. M., Saxena, S., Dancis, A., and Pain, D. (1999) J. Biol. Chem. 274, 22847-22854[Abstract/Free Full Text]
32. Murakami, H., Pain, D., and Blobel, G. (1988) J. Cell Biol. 107, 2051-2057[Abstract]
33. Gordon, D. M., Qi, S., Dancis, A., and Pain, D. (1999) Hum. Mol. Genet. 8, 2255-2262[Abstract/Free Full Text]
34. Kennedy, M. C., Emptage, M. H., Dreyer, J. L., and Beinert, H. (1983) J. Biol. Chem. 258, 11098-11105[Abstract/Free Full Text]
35. Munujos, P., Coll-Canti, J., Gonzalez-Sastre, F., and Gella, F. J. (1993) Anal. Biochem. 212, 506-509[CrossRef][Medline] [Order article via Infotrieve]
36. Vargas, C., McEwan, A. G., and Downie, J. A. (1993) Anal. Biochem. 209, 323-326[CrossRef][Medline] [Order article via Infotrieve]
37. Yamaguchi-Iwai, Y., Stearman, R., Dancis, A., and Klausner, R. (1996) EMBO J. 15, 3377-3384[Abstract]
38. Gangloff, S. P., Marguet, D., and Lauquin, G. J. (1990) Mol. Cell. Biol. 10, 3551-3561[Medline] [Order article via Infotrieve]
39. Dibrov, E., Fu, S., and Lemire, B. D. (1993) J. Biol. Chem. 273, 32042-32048[Abstract/Free Full Text]
40. Labbe-Bois, R. (1990) J. Biol. Chem. 265, 7278-7283[Abstract/Free Full Text]
41. Rowley, N., Prip-Buus, C., Westermann, B., Brown, C., Schwarz, E., Barrell, B., and Neupert, W. (1994) Cell 77, 249-259[Medline] [Order article via Infotrieve]
42. Westermann, B., and Neupert, W. (1997) J. Mol. Biol. 272, 477-483[CrossRef][Medline] [Order article via Infotrieve]
43. Voisine, C., Schilke, B., Ohlson, M., Beinert, H., Marszalek, J., and Craig, E. A. (2000) Mol. Cell. Biol. 20, 3677-3684[Abstract/Free Full Text]
44. Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., and Kaplan, J. (1997) Science 276, 1709-1712[Abstract/Free Full Text]
45. Branda, S. S., Cavadini, P., Adamec, J., Kalousek, F., Taroni, F., and Isaya, G. (1999) J. Biol. Chem. 274, 22763-22769[Abstract/Free Full Text]
46. Gordon, D. M., Kogan, M., Knight, S. A., Dancis, A., and Pain, D. (2001) Hum. Mol. Genet. 10, 259-269[Abstract/Free Full Text]
47. Beinert, H., and Kiley, P. J. (1999) Curr. Opin. Chem. Biol. 3, 152-157[CrossRef][Medline] [Order article via Infotrieve]
48. Klausner, R. D., Rouault, T. A., and Harford, J. B. (1993) Cell 72, 19-28[Medline] [Order article via Infotrieve]
49. Schilke, B., Voisine, C., Beinert, H., and Craig, E. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 10206-10211[Abstract/Free Full Text]
50. Hartl, F. U. (1996) Nature 381, 571-580[CrossRef][Medline] [Order article via Infotrieve]
51. Craig, E. A. (1993) Science 260, 1902-1903[Medline] [Order article via Infotrieve]
52. Schatz, G., and Dobberstein, B. (1996) Science 271, 1519-1526[Abstract]
53. Land, T., and Rouault, T. A. (1998) Mol. Cell 2, 807-815[Medline] [Order article via Infotrieve]
54. Tong, W.-H., and Rouault, T. (2000) EMBO J. 19, 5692-5700[Abstract/Free Full Text]
55. Knight, S. A. B., Kim, R., Pain, D., and Dancis, A. (1999) Am. J. Hum. Genet. 64, 365-371[CrossRef][Medline] [Order article via Infotrieve]
56. Wiley, J. S., and Moore, M. R. (2000) in Hematology: Basic Principles and Practice (Hoffman, R. , Benz, E. , Shattil, S. , Furie, B. , Cohen, H. , Silberstein, L. , and McGlave, P., eds) , pp. 11428-11445, Churchill Livingstone, Philadelphia
57. Allikmets, R., Raskind, W. H., Hutchinson, A., Schueck, N. D., Dean, M., and Koeller, D. M. (1999) Hum. Mol. Genet. 8, 743-749[Abstract/Free Full Text]
58. Bekri, S., Kispal, G., Lange, H., Fitzsimons, E., Tolmie, J., Lill, R., and Bishop, D. F. (2000) Blood 96, 3256-3264[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.